Msd Partners, L.P. P Lx Pharma Inc. Transaction History

Msd Partners, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jun 22, 2023	SELL	$0.52 - $3.08 $297,024 - $1.76 Million	-571,200 Reduced 30.46%	1,303,800 $677,000
Q3 2022 Nov 14, 2022	SELL	$0.52 - $3.08 $297,024 - $1.76 Million	-571,200 Reduced 30.46%	1,303,800 $847,000
Q1 2022 Jun 22, 2023	SELL	$3.54 - $8.3 $13.3 Million - $31.1 Million	-3,750,000 Reduced 66.67%	1,875,000 $7.58 Million
Q4 2021 Jun 22, 2023	BUY	$7.69 - $19.66 $28.8 Million - $73.7 Million	3,750,000 Added 200.0%	5,625,000 $45.1 Million
Q2 2021 Jun 22, 2023	BUY	$9.0 - $15.94 $16.9 Million - $29.9 Million	1,875,000 New	1,875,000 $25.9 Million
Q1 2021 May 17, 2021	BUY	$5.24 - $10.14 $9.83 Million - $19 Million	1,875,000 New	1,875,000 $16.9 Million

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Msd Partners, L.P. with notifications on news.